ESMO: Moderna’s mRNA solid tumour vaccine shows early promise

Moderna’s mRNA cancer vaccine for solid tumours shows early signs of promise in interim data from a Phase I study.

The messenger ribonucleic acid (mRNA) specialist announced the vaccine has shown early signs of an immune response against cancer, with the shot triggering cancer-killing cells.